Literature DB >> 2538256

Hepatocellular carcinoma in adenomatous hyperplasia of the liver.

M Sakurai1, K Wakasa, M Monden, T Yamada, C Kuroda, T Marukawa, J Okamura.   

Abstract

A hepatocellular carcinoma (HCC) measuring 0.2 cm in diameter was found in the center of an adenomatous hyperplasia (AH) measuring 1.7 cm in diameter in a cirrhotic liver. The liver cells of the AH showed a marked fatty change and contained many Mallory bodies. The AH and HCC were studied in relation to liver cell dysplasia in 108 surgically resected livers. The AH was mainly associated with fully developed cirrhosis in 5 (71%) of the 7 cases. The liver cell dysplasia, however was accompanied largely by fibrosis and early-stage incomplete septal cirrhosis in 10 (67%) of the 15 cases. As far as the active inflammatory change was concerned, a fairly active inflammation was found in only 3 (20%) of the 15 livers with liver cell dysplasia, but in 4 (57%) of the 7 livers with AH.

Entities:  

Mesh:

Year:  1989        PMID: 2538256     DOI: 10.1007/bf00647253

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  6 in total

1.  Early recognition of hepatocellular carcinoma.

Authors:  K Okuda
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

2.  Liver cell dysplasia and hepatitis B surface and core antigens in cirrhosis and hepatocellular carcinoma of autopsy cases.

Authors:  M Sakurai
Journal:  Acta Pathol Jpn       Date:  1978-09

Review 3.  Pathologic aspects of cirrhosis. A review.

Authors:  H Popper
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

4.  Cirrhosis and primary cancer of the liver. Comparative study in Tokyo and Cincinnati.

Authors:  W Mori
Journal:  Cancer       Date:  1967-05       Impact factor: 6.860

5.  Liver cell dysplasia: a premalignant condition.

Authors:  P P Anthony; C L Vogel; L F Barker
Journal:  J Clin Pathol       Date:  1973-03       Impact factor: 3.411

6.  Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases.

Authors:  M Arakawa; M Kage; S Sugihara; T Nakashima; M Suenaga; K Okuda
Journal:  Gastroenterology       Date:  1986-07       Impact factor: 22.682

  6 in total
  6 in total

1.  Hepatocellular carcinoma coexistent with adenomatous hyperplasia: report of a case.

Authors:  K Kurita; A Yoshida; G Tanabe; K Shirao; M Hamanoue; T Aikou; H Shimazu
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  A case report of hepatocellular carcinoma within adenomatous hyperplasia: is adenomatous hyperplasia a precancerous lesion or not?

Authors:  A Itoh; H Taniguchi; K Sawai; T Takahashi; K Kawamoto; T Deguchi; K Kagawa
Journal:  Gastroenterol Jpn       Date:  1991-08

3.  Computed tomography during arteriography and arterial portography in small hepatocellular carcinoma and dysplastic nodule: a prospective study.

Authors:  S Mikami; S Kubo; K Hirohashi; T Shuto; H Kinoshita; K Nakamura; R Yamada
Journal:  Jpn J Cancer Res       Date:  2000-08

4.  Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogen-induced hepatic nodules in rats.

Authors:  T Ikebe; T Yamamoto; S Kubo; K Hirohashi; H Kinoshita; K Kaneda; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1998-02

5.  Sinusoidal capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat.

Authors:  T Yamamoto; K Kaneda; K Hirohashi; H Kinoshita; M Sakurai
Journal:  Jpn J Cancer Res       Date:  1996-05

6.  Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; T Shuto; T Kuroki; S Minamitani; T Ikebe; T Yamamoto; K Wakasa; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1998-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.